Moderna and Merck release melanoma vaccine data early
🤖 AI-generated content — The title and summary were produced automatically by artificial intelligence, without human editorial review.
Moderna and Merck released highly anticipated data on their personalised mRNA melanoma vaccine earlier than expected at ESMO. The reported findings concern recurrence-free survival and the time before cancer spread to distant parts of the body.
Continue in the app — vote & join in ➔Source: STAT News · via ahirlevel.hu